Overview
Project Ronin delivers a Cancer Intelligence Platform as a service to oncology providers (hospitals, cancer centers, and clinics). The platform combines a patient-facing app for symptom tracking and communication with a clinician-facing dashboard that aggregates health data, including treatment history, lab results, and genomic information. It uses data analytics to generate personalized insights and treatment recommendations to help oncologists make better-informed decisions and to improve the patient care experience. The subscription-based model targets the oncology market from small community practices to large academic centers. Unlike generic health IT tools, the platform is purpose-built for cancer care, integrating patient engagement with clinical decision support in a single system. The goal is to improve cancer outcomes and patient experience by enabling data-driven, timely clinical interventions and better coordination between patients and their care teams.
Work here?Claim your company
Simplify's take
What believers are saying
- Providence Saint John's used Ronin's app in 2022, validating real clinical deployment.
- 2026 profile lists 51-200 employees, showing the company still hires and operates.
- Founder access to Oracle-style infrastructure supports larger model training and EHR integration.
What critics are saying
- No fresh 2025-2026 customer wins or financing announcements signal weak momentum.
- Flatiron and EHR incumbents already own oncology workflows and distribution.
- Providence Saint John's partnership dates to 2022; stalling adoption kills category leadership.
What makes Project Ronin unique
- Integrates oncology decision support directly into Epic and Cerner workflows.
- Combines clinician dashboards, patient-reported outcomes, and predictive analytics in one platform.
- Backed by Dave Hodgson, Dr. David Agus, and Larry Ellison, attracting credibility.
Help us improve and share your feedback! Did you find this helpful?